Have any questions?
+44 1234 567 890
March 2, 2017
Turkey Grants Patent for GeneQuine’s Lead Products
Following Europe and China, the Turkish Patent Office grants the Patent for GeneQuine’s Lead Products.
The patent covers helper-dependent adenoviral vectors expressing interleukin-1 receptor antagonist and their use in the treatment of osteoarthritis. With the granted patent, GeneQuine secures intellectual property rights in the Turkish healthcare market, which has a large growth potential. Patent applications for this technology are pending in other regions of the world.